knowledge -WSS

knowledge

author：leisure time 2025-09-30 01:13:37 - browse：53846

Ionis Pharmaceuticals, a California biotech that has spearheaded the development of RNA-targeting medicines, announced on Tuesday that its drug against familial chylomicronemia syndrome, a rare and serious disease that prevents the body from breaking down fats, succeeded in a late-stage clinical trial.

The Phase 3 trial, dubbed Balance, enrolled 66 adults who were randomly divided into three groups and given a monthly injection of placebo or one of two doses of olezarsen, the company’s experimental drug. Treatment with the higher dose of the therapy significantly lowered triglycerides in the blood of those on the drug for six months compared to participants given placebo, though a lower dose did not have this effect. Participants on the high dose didn’t have any instances of painful inflammation of the pancreas, one of the disease’s most serious symptoms, while there were 11 such episodes among those on placebo.

Researchers reported that the treatment was also generally safe, with fewer adverse events among those on olezarsen than among the placebo group.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： CVS Caremark has created a new ploy: the drug ‘rebate credit’

WSS

Plastic surgeons increase patient psychiatric screenings

Asbestos, a deadly carcinogen, banned by EPA

Plastic surgeons increase patient psychiatric screenings

Future doctors should be trained to promote social change

FTC falls short on scrutinizing hospital mergers, study says

MassMutual is introducing free genetic testing for members

focus

knowledge

focus

Medical leaders decry Supreme Court decision on affirmative action

UnitedHealth financials solid despite Change Healthcare cyberattack

Medicare details structure of new drug price negotiation program

Readout Newsletter: Novavax stock, FogPharma, Novo Nordisk

Wildfire smoke exposes gaps in outdoor worker protections

Health care needs a new profession: neuroimaging counseling

The high cost of giving birth even with insurance

Why rehabilitation engineers need to center patients in their research

Affirmative action in medical school literally saved lives

Why does health care cost so much? A reading guide

focus

After traumatic brain injury, life support decisions can use more time

Nurses recount patients attacks

Stop the failed accountable care organization experiment

UnitedHealth increases loan offers after Change Healthcare outage

Melinda French Gates resigns from Gates Foundation

5 to watch: Tech startups trying to solve health care's staffing crisis

Wikipedia

knowledge

entertainment

leisure time